VEEV · Veeva Systems Inc
Market Cap
$46.04B
Shares
161.91M
VEEV metrics
77 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$275.09
Market cap
$46.04B
Price action
19 metricsPrice change (1W)
-0.6%
Price change (30D)
+19.4%
Price change (3M)
+59.4%
Price change (6M)
+40.7%
Price change (YTD)
+23.2%
Price change (1Y)
+1.9%
Trailing year
Price change (5Y)
-13.4%
52-week high
$306.22
52-week low
$151.43
Change from 52-week high
-10.2%
Change from 52-week low
+81.7%
Annualized volatility
42.7%
Beta
0.6
RSI (14D)
65.9
Price vs SMA 50
+25.0%
Price vs SMA 200
+38.5%
Avg volume (3M)
2.06M
Relative volume
0.6
Average dollar volume
$422.87M
Company
3 metricsSector
Healthcare
Industry
Health Information Services
Shares outstanding
161.91M
Valuation
12 metricsP / E (TTM)
45.0
Trailing earnings · reciprocal yield 2.2%
PEG ratio
1.1
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
13.3×
reciprocal yield 7.5%
P / book
6.2
reciprocal yield 16.1%
FCF yield
—
TTM · current market cap
Buyback yield
1.4%
P / FCF
—
P / operating cash flow
27.6
reciprocal yield 3.6%
Earnings yield
2.2%
Historical valuation
8 metricsP / E historical average (3Y)
52.8×
reciprocal yield 1.9%
P / E historical average (5Y)
62.6×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-26
Profitability
9 metricsGross margin
75.0%
Operating margin
29.9%
Trailing 12 months
Net margin
29.3%
Gross profit (TTM)
$2.59B
Operating profit (TTM)
$1.03B
Net income (TTM)
$1.01B
Trailing 12 months
Diluted EPS (TTM)
$6.11
FCF margin
—
Effective tax rate
23.6%
Growth
11 metricsRevenue growth YoY
+17.6%
Year over year
Net income growth YoY
+36.5%
Revenue (TTM)
$3.46B
Trailing 12 months
EPS growth YoY
+39.5%
Shares change YoY
-1.6%
Year over year · fewer shares
Revenue CAGR (3Y)
+14.0%
Revenue CAGR (5Y)
+16.9%
EPS CAGR (3Y)
+21.9%
EPS CAGR (5Y)
+18.2%
FCF CAGR (3Y)
+46.9%
FCF CAGR (5Y)
+60.3%
Quality
14 metricsReturn on equity
13.7%
Return on assets
11.2%
Debt / equity
—
Current ratio
5.5
EBITDA (TTM)
$306.08M
Free cash flow (TTM)
—
Quick ratio
5.5
Interest coverage
—
Net debt / EBITDA
-1.6
Return on invested capital
—
Trailing 12 months
Net cash
$1.81B
Latest balance sheet
Cash & equivalents
$1.81B
Total assets
$9.06B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$1.67B
Capital expenditures (TTM)
$1.65M
R&D (TTM)
$821.92M
SG&A (TTM)
—
Stock compensation (TTM)
$494.59M
R&D / revenue
23.8%
Stock compensation / revenue
14.3%
Ownership (13F)
3 metrics13F filers
1,073
13F filer change QoQ
+45
Institutional ownership
90.8%
Short interest
3 metricsShort interest
3.6%
Latest settlement · 3.0 days to cover
Days to cover
3.0d
Short-squeeze score
62 / 100
Insider activity
2 metricsNet insider buying (90D)
−$12.82M
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1393052
CUSIP
922475108
13F (30d)
562 filings
555 filers
Visit website
Investor relations